Trial Profile
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 17 Aug 2020 Status changed from active, no longer recruiting to completed.
- 24 Mar 2020 Planned End Date changed from 1 Jan 2020 to 1 Jul 2020.
- 01 Feb 2019 Planned End Date changed from 1 Dec 2018 to 1 Jan 2020.